Literature DB >> 24838799

Clinical outcome of parapneumonic empyema in children treated according to a standardized medical treatment.

Marijke Proesmans1, Brenda Gijsens, Patricia Van de Wijdeven, Herbert De Caluwe, Jan Verhaegen, Katrien Lagrou, Ellen Van Even, Francois Vermeulen, Kris De Boeck.   

Abstract

UNLABELLED: Treatment of parapneumonic empyema (PE) consists of intravenous antibiotics and, in case of large effusions and persisting fever, pleural chest drain (±intrapleural fibrinolytics) or video-assisted surgical intervention. We standardized the treatment for PE in our tertiary care center choosing a first-step nonsurgical approach. The aim was to evaluate the need for surgery and to collect data on disease course, outcome, and microbiology. For all children treated for PE between 2006 and 2013, data were prospectively collected concerning treatment, length of stay, duration of fever, complications, and causative agent. Of 132 children treated for PE, 20 % needed surgical intervention. Analyzed per year, the need for surgery decreased from almost 40 % in 2007 to 0 % in 2010 again increasing to 40 % although this did not reach statistical significance (p = 0.115). Median duration of "in-hospital fever" was 5 days (IQR, 3-8). The duration of fever correlated with pleural LDH (r = 0.324; p = 0.002) and pleural glucose (r = -0.248; p = 0.021) and was inversely correlated with pleural pH (r = -0.249; p = 0.046). Based on pleural PCR data, 85 % of PE were caused by Streptococcus pneumoniae (40 % serotype 1).
CONCLUSION: After introduction of a standardized primary medical approach (chest drain ± fibrinolysis) for PE in our institution, the need for surgical rescue interventions overall remained at 20 %, which is higher than in some other reports. Difference in microbiology or disease severity could not be proven.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24838799     DOI: 10.1007/s00431-014-2319-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  32 in total

1.  Increase in incidence of childhood empyema in West Midlands, UK.

Authors:  J H Rees; D A Spencer; D Parikh; P Weller
Journal:  Lancet       Date:  1997-02-08       Impact factor: 79.321

2.  An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations.

Authors:  Carrie L Byington; LaShonda Y Spencer; Timothy A Johnson; Andrew T Pavia; Daniel Allen; Edward O Mason; Sheldon Kaplan; Karen C Carroll; Judy A Daly; John C Christenson; Matthew H Samore
Journal:  Clin Infect Dis       Date:  2002-01-03       Impact factor: 9.079

Review 3.  Current evidence for the management of paediatric parapneumonic effusions.

Authors:  Emmanouil Paraskakis; Eleni Vergadi; Athanasios Chatzimichael; Demosthenes Bouros
Journal:  Curr Med Res Opin       Date:  2012-05-22       Impact factor: 2.580

4.  Therapy of parapneumonic effusions in children: video-assisted thoracoscopic surgery versus conventional thoracostomy drainage.

Authors:  Beth A Kurt; Kimberly M Winterhalter; Robert H Connors; Bradford W Betz; John W Winters
Journal:  Pediatrics       Date:  2006-08-14       Impact factor: 7.124

5.  Pleural fluid nucleic acid testing enhances pneumococcal surveillance in children.

Authors:  Roxanne E Strachan; Anita Cornelius; Gwendolyn L Gilbert; Tanya Gulliver; Andrew Martin; Tim McDonald; Gillian Nixon; Rob Roseby; Sarath Ranganathan; Hiran Selvadurai; Greg Smith; Manuel Soto-Martinez; Sadasivam Suresh; Laurel Teoh; Kiran Thapa; Claire E Wainwright; Adam Jaffé
Journal:  Respirology       Date:  2012-01       Impact factor: 6.424

6.  Randomised trial of intrapleural urokinase in the treatment of childhood empyema.

Authors:  A H Thomson; J Hull; M R Kumar; C Wallis; I M Balfour Lynn
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

7.  Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001.

Authors:  Steven C Buckingham; Michaela D King; Martha L Miller
Journal:  Pediatr Infect Dis J       Date:  2003-06       Impact factor: 2.129

Review 8.  Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.

Authors:  G L Colice; A Curtis; J Deslauriers; J Heffner; R Light; B Littenberg; S Sahn; R A Weinstein; R D Yusen
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

9.  Pediatric parapneumonic empyema: risk factors, clinical characteristics, microbiology, and management.

Authors:  Galia Grisaru-Soen; Michal Eisenstadt; Gideon Paret; David Schwartz; Nathan Keller; Hagit Nagar; Shimon Reif
Journal:  Pediatr Emerg Care       Date:  2013-04       Impact factor: 1.454

10.  The changing face of pleural empyemas in children: epidemiology and management.

Authors:  Karen D Schultz; Leland L Fan; Jay Pinsky; Lyssa Ochoa; E O'Brian Smith; Sheldon L Kaplan; Mary L Brandt
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124

View more
  1 in total

1.  Human pleural fluid is a potent growth medium for Streptococcus pneumoniae.

Authors:  Natalia D Popowicz; Sally M Lansley; Hui M Cheah; Ian D Kay; Christine F Carson; Grant W Waterer; James C Paton; Jeremy S Brown; Y C Gary Lee
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.